In cardiovascular tissues, statins have been shown to inhibit the increase in ROCK activity induced by Ang II [57] and that AT1 antagonists (ARBs), and statins act synergically to reduce ROCK activity and its deleterious effects on the progression of heart damage and atherosclerosis [57,58,59]. Here, AGTR1 is linked to atherosclerosis.